Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Ceramedix, Inc. Secures $4.5 Million Contract with NIAID to Advance GI-ARS Therapeutic Development.

Aug 11, 2026•about 2 hours ago

Contract Type

contract

New YorkBiotechnologyHealth CareMedicalTherapeutics

Description

Ceramedix, Inc. has been awarded a multi-year contract valued at up to $4.5 million from the NIAID to advance its lead drug candidate aimed at treating gastrointestinal acute radiation syndrome. The funding will support nonclinical studies and the Chemistry, Manufacturing and Controls development essential for an Investigational New Drug application.

Company Information

Company

Ceramedix

Location

New York, New York, United States

About

Ceramedix, Inc. is a privately held biotherapeutics company based in New York City. The company is focused on developing first-in-class drugs to treat diseases of the microvasculature. Their lead drug candidate is aimed at providing treatment for gastrointestinal acute radiation syndrome. Ceramedix's innovative therapies have the potential to revolutionize emergency medical responses.

Predictive Intelligence
Strategic

ML-powered predictions for Ceramedix's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.